---
title: "MARSHALL RICHARD PETER — Ownership Dossier"
canonical: https://whiteintel.dev/entity/67065a67-bfdd-55ac-8a96-716c3bf25d4b
json: https://whiteintel.dev/api/public/dossier/67065a67-bfdd-55ac-8a96-716c3bf25d4b
identifier: sec:0002016188
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MARSHALL RICHARD PETER

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002016188`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/67065a67-bfdd-55ac-8a96-716c3bf25d4b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/67065a67-bfdd-55ac-8a96-716c3bf25d4b  

## Ownership & control

### Holdings / subsidiaries

- **Serina Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/66f81ec4-86e1-5019-af9a-3108276a5ed1

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MARSHALL RICHARD PETER**. Human view: https://whiteintel.dev/entity/67065a67-bfdd-55ac-8a96-716c3bf25d4b · Structured JSON: https://whiteintel.dev/api/public/dossier/67065a67-bfdd-55ac-8a96-716c3bf25d4b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._